Frontiers in Parkinson’s Disease Research: What’s New for You

Join us April 28th from 12:00 p.m. to 5 p.m. at the Hilton Garden Inn in Lebanon, NH to hear current findings and future directions of research for people with Parkinson’s Disease.

Speakers:

Stephen L. Lee, MD PhD is a Movement Disorders Specialist in the Department of Neurology at Dartmouth-Hitchcock Medical Center. He completed his PhD and MD at Washington University School of Medicine and his Neurology Residency in St. Louis. Dr. Lee joined DHMC after completing his Movement Disorders Fellowship at Vanderbilt University Medical Center in 2004. He is co-founder and co-director of the Parkinson’s and Movement Disorders Center at DHMC and Assistant Professor at Geisel School of Medicine at Dartmouth. Dr. Lee is a member of the Parkinson’s Study Group, which is a non-profit group of physicians and other health care providers experienced in the care of people with Parkinson’s and dedicated to clinical research of Parkinson’s disease.

Matthew C. Havrda, PhD is an Associate Professor in Molecular and Systems Biology at Dartmouth School of Medicine. His laboratory studies cellular and molecular mechanisms of neuroinflammation in the contexts of toxicant exposure and Parkinson’s disease. He is primarily responsible for running his own NIH-funded research program, directing Dartmouth’s graduate course “Neurobiology of Disease” while training and mentoring students and postdoctoral fellows. Dr. Havrda is a full member of the Society of Neuroscience and the Society for Toxicology. He is the Program Director of a multi-institution NIEHS Virtual Consortium for Translational/Transdisciplinary Environmental Research (ViCTER), in which he oversees work conducted at Dartmouth, the University of Georgia, and White River Junction VA Medical Center to understand Parkinson’s disease risk in military veterans. Dr. Havrda is a full member of the Society of Neuroscience and the Society for Toxicology (SOT). Dr. Havrda is an active member of the SOT Neurotoxicology Specialty Section and the New England Chapter of SOT.  Dr. Havrda is a standing member of the National Institutes of Health (NIH), Neurotoxicology and Alcohol [NAL] Study Section and serves on Department of Defense Congressionally Directed Medical Research Programs, Neurotoxin Exposure Treatment Parkinson’s (NETP) Study Section, NIH/NIEHS The Outstanding New Environmental Scientist (ONES) Award Study Section, and NIH Special Emphasis Panel, Evaluation of the R01 Victer (TT) Environmental Research Grant Applications.  He has authored dozens of peer reviewed publications and provided numerous invited review articles and seminars on the biology of Parkinson’s disease. 

Mary S. Feldman, DO serves as the Co-director for the Parkinson’s and Movement Disorders Clinic and Director for the Residency Program for Neurology at Dartmouth Hitchcock Medical Center. She completed her Neurology residency at University of Pittsburgh Medical Center and movement fellowship at Cleveland Clinic where she received the Excellence in Research Award. She has served as the Director for Movement Disorders at Wright State University and the Medical Director of Stroke at Penn Highlands Healthcare. She is currently a member of the International Parkinson’s and Movement Disorders Society, the American Academy of Neurology, and the American Academy of Osteopathic Neurology and Psychiatry. She has served as the PI or co-investigator in multiple research studies spanning everything from the effects of exercise on Parkinson’s Disease to deep brain stimulation therapy to non-motor symptoms such as constipation in Parkinson’s Disease.

Karl Biggs, BS is a PhD candidate focusing on neurodegeneration, cell biology and proteomics at Dartmouth College. Karl earned his Bachelors of Science in Neuroscience from UCLA in 2018. He has been researching Parkinson’s disease and other neurodegenerative diseases for over 8 years and has been involved in a variety of projects including the development of novel techniques for biomarker discovery, investigating the biophysical basis of alpha synuclein aggregation and toxicity, and most recently exploring the biological mechanisms behind alpha synuclein processing and how this contributes to neuroinflammation. He hopes that his current research will contribute new therapeutic targets and biomarkers to the community. 

Agenda:

12:00 PM    REGISTRATION TABLE OPENS

12:30 PM    WELCOME

Melanie L. Del Frari, MSN, APRN

12:40 PM   PDGENERATION: MAPPING THE FUTURE OF PARKINSONS DISEASE

Kelly Nicoll, MSW, MBA

1:00 PM        Q&A and DISCUSSION

1:10 PM       IMFLAMMASOMES AND PARKINSON’S DISEASE

Matthew C. Havrda, PhD

1:40 PM        Q&A and DISCUSSION

1:50 PM       RESEARCH IN EXERCISE: UPDATES

Mary S. Feldman, DO

2:20 PM        Q&A and DISCUSSION

2:30 PM          EXERCISE BREAK

2:45 PM        DARTMOUTH HEALTH RESEARCH: WHAT TO KNOW AND HOW TO ENROLL

Charlotte Jeffreys, CCRC

3:00 PM       EXHIBIT HALL AND LIGHT REFRESHMENTS

3:30 PM        CROSSROADS OF NEUROINFLAMMATION, ALPHA SYNUCLEIN AND EXTRACELLULAR VESSICLE RELEASE

Karl Biggs, BS Neuroscience

4:00 PM        Q&A and DISCUSSION

4:10 PM      BUILDING FOUNDATIONAL TOOLS FOR RESEARCH IN PARKINSON’S DISEASE

Stephen Lee, MD, PhD

4:40 PM        Q&A and DISCUSSION

4:50 PM        CLOSING REMARKS

For more information or help with registration, contact us at movement@hitchcock.org or call us at (603) 650-1865.